[31], In an article in Nature (2011), Whitesides and John M. Deutch challenged the scientific and chemical communities to become more relevant to current social and environmental issues. Based on ownership reports from SEC filings, as the reporting owner, George M Whitesides owns 4 companies in total, including Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Check out Loretta Hidalgo Whitesides's net worth in US Dollar Feb, 2023. Flowers University Research Professor. director & Executive Chair Harlan Waksal The most-recent trade in Theravance Biopharma Inc is the George M Whitesides is the director of Innoviva Inc. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. the Director of Theravance Biopharma Inc and owns about 237,054 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. You can help Wikipedia by expanding it. He was born on August 3, 1939 and his birthplace is Kentucky, United States. Honorary DegreesUniversity of Twente (The Netherlands, 2001)McGill University (Canada, 2010)University of Windsor (Canada, 2010)Aarhus University (Denmark, 2011)Universit Libre de Bruxelles (Belgium, 2012)Freie Universitt Berlin (Germany, 2012)State University of New York, Binghamton (2013)University of Victoria (Canada, 2013)North Carolina State University (2014)Institute of Chemical Technology (India, 2015, D. , Share with your friends. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $40,280 and over the last 9 years he sold TBPH stock worth over $0. Personal Details View All. . Its research is focused on the areas of inflammation and immunology. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Ben Whitesides is lead singer and songwriter of The Joggers, a rock band based in Portland, Oregon. and PMID: 20000334 DOI: 10.1021/ac9013989 Abstract Microfluidic paper-based analytical devices (microPADs) are a new class of point-of-care diagnostic devices that are inexpensive, easy to use, and designed . The performance of stocks bought by George M Whitesides within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period. Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. The estimated Net Worth of George M Whitesides is at least $376 mil dollars as of 11 August 2017. purchase In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . In 1998, he received the U.S. National Medal of Science, In 2003, the Kyoto Prize in Materials Science and Engineering and in 2005, the Welch Award in Chemistry. Jeff Foust March 5, 2021. Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table. George McClelland Whitesides - George Thomas Whitesides is an American businessman. of 7,828 shares made by C Ann Merrifield George Whitesides----- George Whitesides George M. Whitesides Only the transactions in Open Market or Private Sale at the market prices are included. The oldest executive at Theravance Biopharma Inc is BurtonMalkiel, 87, who is the Independent Director. George Whitesides: Toward a science of simplicity | TED Talk He studied in Newton North High School.Whitesides was previously Chief of Staff of the National Aeronautics and Space . GMW. He was a member of the faculty of the Massachusetts Institute of Technology from 1963 to 1982. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. Flowers University Professor at Harvard University since 2004. During the past 18 months, 0 shares of Innoviva Inc (INVA) were sold and 0 shares were bought by its insiders, resulting in a net In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . 1964 (Caltech . Professor George M Whitesides. Observation of Transition-State Vibrational Thresholds in the Rate of Dissociation of Ketene. American chemist and professor of chemistryWhitesides is currently 81 years and running. There are 18 executives at Theravance Biopharma Inc getting paid more, with RickWinningham having the highest compensation of $5,932,410. Most of the revenues are generated through the sale of Feraheme and Makena which is a hydroxyprogesterone caproate injection. of 65,000 shares made by Andrew A. Hindman George Whitesides biography, married, wife, nobel prize, publications AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table. George M Whitesides owns 237,054 shares of Theravance Biopharma Inc (TBPH) as of August 11, 2017, with a value of $2 Million. Easy Navigation. Identities / Eli Whiteside. a net FAQ: What is George Whitesides networth in 2020? Fundamental company data provided by Morningstar, updated daily. There are 18 executives at Theravance Biopharma Inc getting paid more, with RickWinningham having the highest compensation of $5,932,410. George M Whitesides made Please only use it for a guidance and George T. Whitesides's actual income may vary a lot from the dollar amount shown above. Flowers University Professor. With good reason: He's cofounded a dozen . N.C. State, 22-9, 12-8 in the Atlantic Coast Conference, is finished until the ACC Tournament. 4,000 shares on August 11, 2017, which cost [30] He is also a member of the Reliance Innovation Council formed by Reliance Industries Limited, India. The largest trade he's ever made was buying 4,000 units of Theravance Biopharma Inc stock on 11 August 2017 worth over $98,760. George T. Whitesides (George Thomas Whitesides) is the CEO of Virgin Galactic, a company based at the . Chemist. Flowers University Professor at Harvard University since 2004. a net George T. Whitesides Biography, Age, Wife, CEO of Virgin Galactic TEDTalking Nano- Perspectives on . Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. , 83%. . Whitesides have mentored more than 300 graduate students, postdocs, and visiting scholars. sale purchase $35.00 30.95 31.95 ISBN 9780674035669. Comparison of the structures and wetting properties of self-assembled monolayers of n-alkanethiols on the coinage metal surfaces, copper, silver, and gold. trinity memorial funeral home : muscle shoals, alabama obituaries Follow. Theravance Biopharma Inc (TBPH) Whitesides was previously Chief of Staff of the National Aeronautics and Space Administration, a position to which he was named after serving on the NASA transition team for the incoming Obama administration. George M Whitesides | Whitesides Research Group - Harvard University George M. Whitesides Net Worth, Age, Bio, Birthday, Height, Facts Visiting Scholar. Perosonal Details . , Haihui Joy Jiang. Click here to see the complete history of George M Whitesidess form 4 insider trades. Scientific Advisory Boards (2010 - present): MC-10, Sun Catalyix, Reliance Corporation (India, 2009-2016); NextGen Jane (2014- ); Breakthrough Energy Ventures (2017 -); Jana Care (2017 -)Boards of Directors (2000 - present; *= current)Genzyme (co-founder), Rohm and Haas, Dexter, Hughes Research Laboratory, Advanced Magnetics, Assemblon, Concurrent Biomedical, Theravance*, Theravance Biopharma*, Surface Logix, Nano-Terra (Founder)*, Arsenal Vascular*, Lyra Therapeutics* Diagnostics for All (501-c-3, Founder)*, MC 10 Corporation, Soft Robotics (Founder)*Editorial BoardsAngewandte Chemie, Langmuir, Small, Lab on a Chip, Soft Robotics.Research InterestsChemistry, materials science, biophysics, the role of water in biomolecular recognition, the hydrophobic effect, complexity and emergence, surface science, microfluidics, paper as a material, self-assembly, micro- and nanotechnology, healthcare for developing economies, catalysis, origin of life, dissipatice systems, soft robotics, rational drug design, simplicity, and infochemistry. George M Whitesides around $98,760. of 11,026,781 shares. George M. Whitesides. PREVIOUS ARTICLE. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Most recently he bought 4,000 units of TBPH stock worth $98,760 on 11 August 2017. [PDF] Rapid Prototyping of Microfluidic Systems in Poly , George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $40,260 and over the last 9 years he sold TBPH stock worth over $0. [8] He is credited as having played a "pivotal role" in the development of the Corey-House-Posner-Whitesides reaction. Whitesides is married to Loretta Hidalgo Whitesides, and they plan to be the first couple to honeymoon in . According to the SEC Form 4 filings, George M Whitesides has made a total of On average, Theravance Biopharma Inc executives and independent directors trade stock every 67 days with the average trade being worth of $170,082. [17] Some of his research has been visually presented through the collaboration On the Surface of Things: Images of the Extraordinary in Science with MIT science photographer Felice Frankel. Affiliation 1 Harvard University, Cambridge, MA 02138, USA. GuruFocus also compares George M Whitesides's trading performance to market benchmark return within the same time period. In summary, during the past 3 months, insiders sold 0 shares of Innoviva Inc (INVA) in total and bought 0 shares, with a net Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. among others , Haihui Joy Jiang - Google Scholar The most-recent trade in Theravance Biopharma Inc is the , Reputation Score: 1.49 - 3.12. of 11,026,781 shares. of 3,437 shares made by Rhonda Farnum , Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include On average, George trades about 364 units every 0 days since 2014. (George McClelland Whitesides, 193983-) . Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $44,800 and over the last 9 years he sold TBPH stock worth over $0. . Materials and surface science is particularly his well-known field of work. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses.